Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis.

Our findings suggest that pooled FA + AP treatment improves negative symptoms in schizophrenia patients. Moreover, this treatment was well tolerated. However, because our results might exhibit a small-study effect, future studies with a larger sample should be conducted to obtain more robust results.